Evidence map›Paper›PMID 36851799›Full record

ArticleViruses2023

Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil.

Mariane Talon de Menezes, Filipe Romero Rebello Moreira, Charles Whittaker, Franciele Martins Santos, Daniel Costa Queiroz, Victor Geddes, Paula Luize Camargos Fonseca, Jaqueline Góes de Jesus, Franciane Mendes-Oliveira, Valquíria Reis-Souza and 11 more

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Mariane Talon de MenezesLaboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil.ORCID 0000-0002-1042-2990
Filipe Romero Rebello MoreiraLaboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil.
Charles WhittakerMRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK.
Franciele Martins SantosLaboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil.
Daniel Costa QueirozLaboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil.ORCID 0000-0002-6607-8818
Victor GeddesLaboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil.
Paula Luize Camargos FonsecaLaboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil.ORCID 0000-0002-8103-9235
Jaqueline Góes de JesusInstitute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil.ORCID 0000-0002-5404-272X
Franciane Mendes-OliveiraInstitute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil.ORCID 0000-0002-6952-7949
Valquíria Reis-SouzaInstitute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil.
Bibiana SantosMendelics Genomic Analysis, São Paulo 04023, Brazil.ORCID 0000-0002-1672-2839
Danielle Alves Gomes ZauliPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.
Aline Brito de LimaPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.ORCID 0000-0001-6192-3587
Cristiane de Brito MendonçaPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.ORCID 0000-0002-7031-2902
Luige Biciati AlvimPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.ORCID 0000-0003-3432-8146
Joice do Prado SilvaPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.ORCID 0000-0001-9553-4328
Frederico Scott Varella MaltaPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.ORCID 0000-0001-9495-0987
Alessandro Clayton de Souza FerreiraPardini Group, Research and Development Department, Belo Horizonte 31270, Brazil.
Nuno R FariaMRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK.
Ester Cerdeira SabinoInstitute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil.ORCID 0000-0003-2623-5126
Renato Santana AguiarLaboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil.ORCID 0000-0001-5180-3717

Funding

Medical Research Council MR/S019510/1
6 · The paper itself

Abstract

Brazil is one of the nations most affected by Coronavirus disease 2019 (COVID-19). The introduction and establishment of new virus variants can be related to an increase in cases and fatalities. The emergence of Omicron, the most modified SARS-CoV-2 variant, caused alarm for the public health of Brazil. In this study, we examined the effects of the Omicron introduction in Minas Gerais (MG), the second-most populous state of Brazil. A total of 430 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) samples from November 2021 to June 2022 from Belo Horizonte (BH) city were sequenced. These newly sequenced genomes comprise 72% of all previously available SARS-CoV-2 genomes for the city. Evolutionary analysis of novel viral genomes reveals that a great diversity of Omicron sublineages have circulated in BH, a pattern in-keeping with observations across Brazil more generally. Bayesian phylogeographic reconstructions indicate that this diversity is a product of a large number of international and national importations. As observed previously, São Paulo state is shown as a significant hub for viral spread throughout the country, contributing to around 70% of all viral Omicron introductions detected in MG.

Indexed as

COVID-19SARS-CoV-2Bayes TheoremBrazilHumansgenomic surveillanceOmicronSARS-CoV-2variants of concernviral evolution

Identifiers

PMID36851799
PMCPMC9962645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.